Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, has received two one-day suspension orders for drug licenses from drug control authorities. The first order from Nizamabad, Telangana affects a store at Metpally Road Armoor, received on May 8, 2026, with a potential revenue loss of Rs 0.09 lakhs. The second order from Bidar Circle, Karnataka affects a store at Shivnagar Bidar with a potential revenue loss of Rs 0.15 lakhs. Both violations relate to Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The combined financial impact is minimal at Rs 0.24 lakhs.
The suspension orders represent a minor regulatory compliance issue for the subsidiary with negligible financial impact. While not material to the company's overall operations, this highlights ongoing compliance requirements in the pharmacy retail business and could attract regulatory scrutiny on store-level operations.